A Challenging Management of Pseudomonas Perforated Corneal Ulcer with Multilayer Amniotic Membrane Transplantation and Pericardial Patch Graft in Pediatric Patient
Downloads
Introduction: Pseudomonas aeruginosa (P. aeruginosa) is the leading cause of corneal ulcers in children 0 to 3 years of age compared to children in general. Case presentation: A two-months-old infant presented with whitish patches on the right eye two days before admission. A central corneal ulcer with a size of 7-mm x 7-mm accompanied by corneal thinning and melting was shown on the right cornea. It is was surrounded by greyish white creamy infiltrates. Corneal scraping showed Pseudomonas aeruginosa specimens. The cornea became perforate and crystalline lens extrusion was found at the day after intravenous ceftriaxone, levofloxacin eye drop, and cefazoline fortified eye drop administering. It might be caused by bacterial elastase and toxin which contributed to corneal damage. The patient was underwent a multilayer Amniotic Membrane Transplantation (AMT) combined with a pericardial patch graft due to corneal perforation. Two months post-AMT and pericardial patch graft the corneal perforation became entirely heal due to multilayer AMT, despite lysis of the pericardial patch graft. Corneal scar formation and reduction of vitreous opacity in ultrasound examination were shown. The patient was planned to undergo keratoplasty. Conclusions: Corneal ulcers due to Pseudomonas aeruginosa are highly destructive. The levels of infection, diagnostic, and therapeutic are still problems in pediatric patients. Lens extrusion and lysis of the pericardial patch graft are examples in this case. Keratoplasty is the definitive treatment for corneal ulcers with perforation; however, multilayer AMT combined with pericardial patch graft can be used as an alternative therapy to accelerate wound healing, reduce inflammation, and maintain the integrity of the eyeball.
Suwal S, Bhandari D, Thapa P, Shrestha MK, Amatya J. Microbiological profile of corneal ulcer cases diagnosed in a tertiary care ophthalmological institute in Nepal. BMC Ophthalmol 2016;16:209. https://doi.org/10.1186/s12886-016-0388-9.
Ung L, Acharya NR, Agarwal T, Alfonso EC, Bagga B, Bispo PJ, et al. Infectious corneal ulceration: A proposal for neglected tropical disease status. Bull World Health Organ 2019;97:854–856. https://doi.org/10.2471/BLT.19.232660.
Chirinos-Saldaña P, Bautista de Lucio VM, Hernandez-Camarena JC, Navas A, Ramirez-Miranda A, Vizuet-Garcia L, et al. Clinical and microbiological profile of infectious keratitis in children. BMC Ophthalmol 2013;13:54. https://doi.org/10.1186/1471-2415-13-54.
Hong J, Chen J, Sun X, Deng SX, Chen L, Gong L, et al. Paediatric bacterial keratitis cases in Shanghai: Microbiological profile, antibiotic susceptibility and visual outcomes. Eye (Lond) 2012;26:1571–1578. https://doi.org/10.1038/eye.2012.210.
Nicula C, Szabo I. Complicated corneal ulcer. Case report. Rom J Ophthalmol 2016;60:260–263.
Al Otaibi AG, Allam K, Damri AJ, Shamri A Al, Kalantan H, Mousa A. Childhood microbial keratitis. Oman J Ophthalmol 2012;5:28–31. https://doi.org/10.4103/0974-620X.94763.
Colby K, editor. Corneal Diseases in Children. 1st ed. Manhattan: Springer, Cham; 2017.
Gao N, Kumar A, Yu F-SX. Matrix Metalloproteinase-13 as a target for suppressing corneal ulceration caused by Pseudomonas aeruginosa infection. J Infect Dis 2015;212:116–127. https://doi.org/10.1093/infdis/jiv016.
Levin LA, Albert DM. Infectious Keratitis. Ocul. Dis. Mech. Manag. 1st ed., Amsterdam: Elsevier Inc; 2010, p. 49–54.
Michael KB, Rotchford A, Ramaesh K. Conjunctival chemosis as a specific feature of Pseudomonas aeruginosa corneal ulcers. Cornea 2016;35:1182–1184. https://doi.org/10.1097/ICO.0000000000000947.
Oka N, Suzuki T, Ishikawa E, Yamaguchi S, Hayashi N, Gotoh N, et al. Relationship of virulence factors and clinical features in keratitis caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 2015;56:6892–6898. https://doi.org/10.1167/iovs.15-17556.
Sihota R, Tandon R. Disease of the Cornea. Parsons' Dis. Eye. 21st ed., Amsterdam: Elsevier Inc; 2011, p. 200–205.
Kenia VP, Kenia R V, Pirdankar OH. Diagnosis and management protocol of acute corneal ulcer. Int J Heal Sci Res 2020;10:69–78.
Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context 2018;7:212527. https://doi.org/10.7573/dic.212527.
Gupta S, Mittal S, Nayak N, Satpathy G, Khokhar S, Agarwal T. In vitro antibiotic susceptibility of Pseudomonas aeruginosa corneal ulcer isolates. Ocul Immunol Inflamm 2015;23:252–255. https://doi.org/10.3109/09273948.2014.883545.
Alio JL, Rodriguez AE, Martinez LM. Bovine pericardium membrane (tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers. Cornea 2013;32:619–624. https://doi.org/10.1097/ICO.0b013e31825a6d9a.
Yokogawa H, Kobayashi A, Yamazaki N, Masaki T, Sugiyama K. Surgical therapies for corneal perforations: 10 years of cases in a tertiary referral hospital. Clin Ophthalmol 2014;8:2165–2170. https://doi.org/10.2147/OPTH.S71102.
Abdulhalim B-EH, Wagih MM, Gad AAM, Boghdadi G, Nagy RRS. Amniotic membrane graft to conjunctival flap in treatment of non-viral resistant infectious keratitis: A randomized clinical study. Br J Ophthalmol 2015;99:59–63. https://doi.org/10.1136/bjophthalmol-2014-305224.
Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol 2014;4:422. https://doi.org/10.3389/fmicb.2013.00422.
Zuorro A, Fidaleo M, Lavecchia R. Solubility enhancement and antibacterial activity of chloramphenicol included in modified β-cyclodextrins. Bull Korean Chem Soc 2020;31:3460–3462. https://doi.org/10.5012/BKCS.2010.31.11.3460.
Ranch K, Patel H, Chavda L, Koli A, Maulvi F, Parikh RK. Development of in situ ophthalmic gel of dexamethasone sodium phosphate and chloramphenicol: A viable alternative to conventional eye drops. J Appl Pharm Sci 2017;7:101–108. https://doi.org/10.7324/JAPS.2017.70316.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
